α- and β-Adrenoceptors: From the Gene to the Clinic. 1. Molecular Biology and Adrenoceptor Subclassification

Journal of Medicinal Chemistry

Volumn 38, Issue 18, 1995, Pages 3415-3444

  Hieble, J Paul ^a   Bondinell, William E ^a   Ruffolo, Robert R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; 5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ABANOQUIL; ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETAXOLOL; CARAZOLOL; CHLOROETHYLCLONIDINE; DICHLORISOPRENALINE; DOXAZOSIN; IMILOXAN; INDORAMIN; ISOPRENALINE; NIGULDIPINE; NORADRENALIN; PHENTOLAMINE; PINDOLOL; PRAZOSIN; PROPRANOLOL; RAUWOLSCINE; RECEPTOR SUBTYPE; SALBUTAMOL; TERAZOSIN; UNINDEXED DRUG; XAMOTEROL; YOHIMBINE;

ACUTE HEART INFARCTION; ADRENERGIC TRANSMISSION; BINDING AFFINITY; DIABETES MELLITUS; HUMAN; HUMAN CELL; HYPERTENSION; MOLECULAR BIOLOGY; OBESITY; RECEPTOR AFFINITY; REVIEW; SECONDARY PREVENTION;

ANIMAL; HUMAN; MOLECULAR BIOLOGY; MOLECULAR STRUCTURE; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA;

EID: 0029134812     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00018a001     Document Type: Article

References (273)

1. Lands, A. M.; Arnold, A.; McAuliff, J. P.; Luduena, F. P.; Brown, T. G. Differentiation of receptor systems activated by sympathomimetic amines. Nature 1967, 214, 597-598.
2. Langer, S. Z. Presynaptic regulation of catecholamine release. Br. J. Pharmacol. 1974, 60, 481-497.
3. 1-adrenergic receptor. Proc. Natl. Acad. Sci. U. SA. 1988, 85, 7159-7163.
4. Volgt, M. M.; Kiepert, J.; Chin, H. Sequence of a rat brain cDNA encoding an alphalB adrenergic receptor. Nucleic Acids Res. 1990, 18, 1053.
5. Lomasney, J. W.; Cotecchia, S.; Lefkowitz, R. J.; Caron, M. G. Molecular biology of α-adrenergic receptors: Implications for receptor classification and for structure-function relationships. Biochim. Biophys. Acta 1991, 1095, 127-139.
6. Ramarao, C. S.; Denker, J. M. C.; Perez, D. M.; Gaivin, R. J.; Rick, R. P.; Graham, R. M. Genomic organization and expression of the human αis-adrenergic receptor. J. Biol. Chem. 1992, 267, 21936-21945.
7. Libert, F.; Parmentier, M.; Lefort, A.; Dinsart, C.; Van Sande, J.; Maenhaut, C.; Simons, M.; Dumont, J. E.; Vassart, G. Selective amplification and cloning of four new members of the G-protein-coupled receptor family. Science 1989, 244, 569-572.
8. Lomasney, J. W.; Cotecchia, S.; Lorenz, W.; Leung, W. Y.; Schwinn, D. A.; Yang-Feng, T. L.; Brownstein, M.; Lefkowitz, R. J.; Caron, M. G. Molecular cloning and expression of the cDNA for the αu-adrenergic receptor: the gene for which is located on human chromosome 5. J. Biol. Chem. 1901, 266, 6365-6369.
9. 1D-adrenergic receptor cDNA. Mol. Pharmacol. 1991, 40, 876-883.
10. Bylund, D. B.; Eikenberg, D. C.; Hieble, J. P.; Langer, S. Z.; Lefkowitz, R. J.; Minneman, K. P.; Molinoff, P. B.; Rufiblo, R. R., Jr.; Trendelenburg, U. Adrenergic Receptor Subtypes: International Union of Pharmacology Nomenclature of Adrenoceptors. Pharmacol. Rev. 1994, 46, 121-136.
11. 1-Adrenoceptors: Consensus Update. Pharmacol. Rev. 1995, 97, 267-270.
12. Bruno, J. F.; Whittaker, J.; Song, J.; Berelowitz, M. Molecular cloning and sequencing of a cDNA encoding a human αu- adrenergic receptor. Biochem. Biophys. Res. Commun. 1991, 179, 1485-1490.
13. 1c subtype. Mol. Pharmacol. 1994, 45, 703-708.
14. 1-adrenergic receptors: sequence corrections and direct comparisons with other species homologues. J. Pharmacol. Exp. Ther. 1995, 272, 134-142.
15. 1-adrenergic receptor subtype. J. Biol. Chem. 1990, 265, 8183-8189.
16. 1C-adrenergic receptor. Biochem. Biophys. Res. Commun. 1993, 195, 902-909.
17. 1C-adrenergic receptor: Characterization of signal transduction pathways and mammalian tissue heterogeneity. Mol. Pharmacol. 1991, 40, 619-626.
18. 1A subtype. Mol. Pharmacol. 1994, 46, 414-422.
19. 1A-subtype? FASEB J. 1994, 8, A353.
20. 1 Adrenoceptor classification: Sharpening Occam’s razor. Trends Pharmacol. Sci. 1994, 15, 167-170.
21. 1C-adrenergic receptors. FASEB J. 1994, 8, A353.
22. 2-adrenergic receptor. Science 1987, 238, 650-656.
23. 2-adrenergic receptor subtype. Proc. Natl. Acad. Sci. U. S. A. 1988, 85, 6301-6305.
24. 2-adrenergic receptor subtype, the gene for which is located on chromosome 2. Proc. Natl. Acad. Sci. U. SA. 1990, 87, 5094-5098.
25. 2-adrenergic receptor. J. Biol. Chem. 1990, 265, 17307-17317.
26. O’Rourke, M. F.; Iversen, L. J.; Lomasney, J. W.; Bylund, D. B. Species orthologs of the alpha-2A adrenergic receptor: The pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors. J. Pharmacol. Exp. Ther. 1994, 271, 735-740.
27. 2-C4 adrenergic receptor gene encodes a novel pharmacological subtype. FEBS Lett. 1991, 278, 45-50.
28. 2-adrenergic receptor. J. Biol. Chem. 1991, 266, 10470-10478.
29. 2-adrenergic receptor complementary DNA from rat brain. Mol. Cell. Biochem. 1990, 97, 161-172.
30. 2 adrenergic receptor. Biochem. Biophys. Res. Commun. 1992, 186, 1280-1287.
31. 10 homolog responsible for an interspecies variation in antagonist binding. Mol. Pharmacol. 1992, 4, 16-27.
32. 2c-adrenergic receptor from the OK cell line. Mol. Pharmacol. 1994, 45, 176-181.
33. 2-adrenergic receptors: Comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol. Pharmacol. 1992, 42, 1-5.
34. 2-receptor classification. Mol. Pharmacol. 1990, 38, 599-603.
35. 2-adrenergic receptor mRNAs in the rat CNS. Mol. Brain Res. 1991, 10, 219-225.
36. 2-adrenoceptor. Br. J. Pharmacol. 1992, 106, 986-995.
37. 2B-adrenergic receptor. Proc. Natl. Acad. Sci. U. SA. 1990, 87, 3102-3106.
38. Bylund, D. B.; Iversen, L. Low affinity of SK&F 104078 for bovine pineal and rat sublingual alpha-2D adrenergic receptors: A putative presynaptic alpha-2 subtype. Pharmacologist 1990, 32, 144.
39. 2-adrenergic receptors. Mol. Pharmacol. 1991, 40, 407-412.
40. 2A in the rabbit. Naunyn-Schmiedeberg’s Arch. Pharmacol. 1993, 348, 35-45.
41. Dixon, R. A. F.; Kobilka, B. K.; Strader, D. J.; Benovic, J. L.; Dohlman, H. G.; Frielle, T.; Bolanowski, M. A.; Bennett, G. D.; Rands, E.; Diehl, R. E.; Mumford, R. A.; Slater, E. E.; Sigal, I. S.; Caron, M. G.; Lefkowitz, R. J.; Strader, C. D. Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin. Nature 1986, 321, 75-79.
42. Kobilka, B. K.; Frielle, T.; Collins, S.; Yang-Feng, T.; Kobilka, T. S.; Francke, U.; Lefkowitz, R. J.; Caron, M. G. An intronless gene encodes a potential member of a family of receptors coupled to guanine nucleotide regulatory protein. Nature 1987, 329, 75-79.
43. 1A receptor. Nature 1988, 335, 358-360.
44. 1- adrenergic receptor. Proc. Natl. Acad. Sci. U. SA. 1987, 84, 7920-7924.
45. Yarden, Y.; Rodriguez, H.; Wong, S. K. F.; Brandt, D. R.; May, D. C.; Bumier, J.; Harkins, R. M.; Chen, E. Y.; Ramachandran, J.; Ulrich, P.; Ross, E. M. The avian β-adrenergic receptor: Primary structure and membrane topology. Proc. Natl. Acad. Sci. U. SA. 1986, 83, 6795-6799.
46. 1-adrenergic receptor gene. J. Biol. Chem. 1990, 265, 12960-12965.
47. Shimomura, H.; Terada, A. Primary structure of the rat beta-1 adrenergic receptor gene. Nucleic Acids Res. 1990, 18, 4591.
48. Cohen, J. A.; Baggott, L. A.; Romano, C.; Arai, M.; Southerling, T. E.; Young, L. K.; Kozak, C. A.; Molinoff, P. B.; Greene, M. I. Characterization of a mouse βi-adrenergic receptor genomic clone. DNA Cell Biol. 1993, 12, 537-547.
49. Arch, J. R.; Ainsworth, A. T.; Cawthorne, M. A.; Piercy, V.; Sennitt, M. V.; Thod, V. E.; Wilson, C.; Wilson, S. Atypical β-adrenoceptors on brown adipocytes as target for anti-obesity drugs. Nature 1984, 309, 163-165.
50. Wilson, C.; Wilson, S.; Piercy, V.; Sennitt, M. V.; Arch, J. R. S. The rat lipolytic β-adrenoceptor: studies using novel β-adrenoceptor agonists. Eur. J. Pharmacol. 1984, 100, 309-319.
51. 3-adrenergic receptor. Science 1989, 245, 1118-1121.
52. Muzzin, P.; Revelli, J.; Kühne, F.; Gocayne, J. D.; McCombie, W. R.; Venter, J. C.; Giocobino, J.; Fraser, C. M. An adipose tissue-specific β-adrenergic receptor. J. Biol. Chem. 1991, 266, 24053-24058.
53. 3-adrenergic receptor genes contain an intron within the protein coding block. Mol. Pharmacol. 1992, 42, 964-970.
54. 3-adrenergic receptor: relationship with the atypical receptor of adipocytes. EMBO J. 1991, 10, 3721-3727.
55. 3-adrenergic receptor gene contains an intron. FEBS Lett. 1993, 318, 223-226.
56. 3-adrenergic receptor gene. Mol. Pharmacol. 1993, 44, 264-270.
57. 3-adrenergic receptors. FASEB J. 1994, 8, A354.
58. 3- adrenergic receptors: differential agonist activation of recombinant receptors in Chinese hamster ovary cells. Mol. Pharmacol. 1992, 42, 634-637.
59. 3-adrenergic receptor mRNA in man. J. Clin. Invest. 1993, 91, 344-349.
60. 3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human. Mol. Pharmacol. 1992, 42, 343-348.
61. Regan, J. W.; Barden, N.; Lefkowitz, R. J.; Caron, M. G.; DeMarinis, R. M.; Krog, A. H.; Holden, K. G.; Matthews, W. D.; Hieble, J. P. Affinity chromatography of human platelet alpha-2 adrenergic receptors. Proc. Natl. Acad. Sci. U. S. A. 1982, 79, 7223-7227.
62. Shorr, R. G.; Lefkowitz, R. J.; Caron, M. G. Purification of the beta-adrenergic receptor. Identification of the hormone binding subunit. J. Biol. Chem. 1981, 256, 5280-5286.
63. Shorr, R. G.; Heald, S. L.; Jeffs, P. W.; Lavin, T. N.; Strohsacker, M. W.; Lefkowitz, R. J.; Caron, M. G. The beta-adrenergic receptor: Rapid purification and covalent labeling by photoaffinity crosslinking. Proc. Natl. Acad. Sci. U. S. A. 1982, 79, 2778-2782.
64. Findlay, J. B. C.; Pappin, D. J. C. The opsin family of proteins. Biochem. J. 1986, 238, 625-642.
65. 125I]iodobenzene. Biochem. J. 1986, 234, 413-420.
66. Henderson, R.; Baldwin, J. M.; Ceska, T. A. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. Mol. Biol. 1990, 213, 899-929.
67. 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science 1988, 240, 1310-1316.
68. Strader, C. D.; Candelore, M. R.; Hill, W. S.; Dixon, R. A. F.; Sigai, I. S. A single amino acid substitution in the β-adrenergic receptor have promotes partial agonist activity from antagonists. J. Biol. Chem. 1989, 264, 16470-16477.
69. Strader, C. D.; Candelore, M. R.; Hill, W. S.; Sigai, I. S.; Dixon, R. A. F. Identification of two serine residues involved in agonist activation and the β-adrenergic receptor. J. Biol. Chem. 1989, 264, 13572-13578.
70. Strader, C. D.; Sigal, I. S.; Candelore, M. R.; Rands, E.; Hill, W. S.; Dixon, R. A. F. Conserved aspartic acid residues 79 and 113 of the β-adrenergic receptor have different roles in receptor function. J. Biol. Chem. 1988, 263, 10267-10271.
71. Jasper, J. R.; Insel, P. A. Evolving concepts of partial agonism: the β-adrenergic receptor as a paradigm. Biochem. Pharmacol. 1992, 43, 119-130.
72. Aellig, W. H. Investigations with β-adrenoceptor blocking drugs in healthy volunteers. Acta Med. Scand. 1977 (Suppl. 606), 71-75.
73. Hieble, J. P. Structure activity relationships for activation and blockade of β-adrenoceptors. Prog. Basic. Clin. Pharmacol. 1991, 7, 105-172.
74. 2-adrenergic receptor protein based on computer modeling studies. J. Mol. Biol. 1992, 225, 859-871.
75. Dixon, R. A. F.; Sigal, I. S.; Strader, C. D. Structure-Function analysis of the β-adrenergic receptor. Cold Spring Harbor Symp. Quant. Biol. 1988, 53, 487-497.
76. Trumpp-Kallmeyer, S.; Hoflack, J.; Bruinvels, A.; Hibert, M. Modeling of G-protein-coupled receptors: Application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. J. Med. Chem. 1992, 35, 3448-3462.
77. Donnelly, D.; Findlay, J. B. C.; Blundell, T. L. The evolution and structure of aminergic G protein-coupled receptors. Recept. Channels 1994, 2, 61-78.
78. 2- adrenergic receptor modify ligand-binding specificity. Mol. Pharmacol. 1993, 44, 111-114.
79. 2-adrenergic receptors. Proc. Natl. Acad. Sci. U. S. A. 1988, 85, 9494-9498.
80. 2- adrenergic receptors involves multiple subsites. EMBO J. 1990, 9, 1471-1476.
81. 2-adrenergic receptor increases its affinity for a family of β receptor antagonists. J. Biol. Chem. 1991, 266, 15488-15492.
82. Maggio, R.; Vogel, Z.; Wess, J. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intramolecular “cross-talk” between G-protein-linked receptors. Proc. Natl. Acad. Sci. U. SA. 1993, 90, 3103-3107.
83. 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. Mol. Pharmacol. 1991, 40, 168-179.
84. Blaxall, H. S.; O’Rourke, M. F.; Kobilka, B.; Lomasney, J.; Iversen, L. J.; Heck, D. A.; Bylund, D. B. Species characterization of alpha-2A/D adrenergic receptors. Can. J. Physiol. Pharmacol. 1994, 72 (Suppl. 1), 542.
85. 2-adrenergic receptor. Biochemistry 1989, 28, 4125-4130.
86. 2-adrenergic receptors by sodium. J. Biol. Chem. 1990, 265, 21590-21595.
87. 2A-adrenergic receptor that eliminate detectable palmitoylation do not perturb receptor-G-protein coupling. J. Biol. Chem. 1993, 268, 8003-8011.
88. 2A-adrenergic receptor confer short term agonist-promoted desensitization. J. Biol. Chem. 1992, 267, 4740-4746.
89. 1-adrenergic receptor subtypes. FASEB J. 1995, 9, A104.
90. 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc. Natl. Acad. Sci. U. SA. 1990, 87, 2896-2900.
91. Dohlman, H. G.; Caron, M. G.; Lefkowitz, R. J. A family of receptors coupled to guanine nucleotide regulatory proteins. Biochemistry 1987, 26, 2657-2664.
92. Conklin, B. R.; Chabre, O.; Wong, Y. H.; Federman, A. D.; Bourne, H. R. Recombinant Gqα. Mutational activation and coupling to receptors and phospholipase C. J. Biol. Chem. 1992, 267, 31-34.
93. 2-adrenoceptor that blocks coupling to potassium but not calcium currents. Science 1992, 257, 977-980.
94. Barber, D. L.; Ganz, M. B.; Bongiomo, P. B.; Strader, C. D. Mutant constructs of the β-adrenergic receptor that are uncoupled from adenylyl cyclase retain functional activation of Na-H exchange. Mol. Pharmacol. 1992, 41, 1056-1060.
95. McFadzean, I.; Mullaney, I.; Brown, D. A.; Mulligan, G. Antibodies to the GTP binding protein Go, antagonize noradrenaline- induced calcium current inhibition in NG108-15 hybrid cells. Neuron 1989, 3, 177-182.
96. Nichols, A. J. α-Adrenoceptor signal transduction mechanisms. Prog. Basic Clin. Pharmacol. 1991, 7, 44-74.
97. 2-adrenergic receptors to two G-proteins with opposing effects. J. Biol. Chem. 1992, 267, 15795-15801.
98. Duzic, E.; Lanier, S. M. Factors determining the specificity of signal transduction by guanine nucleotide-binding proteincoupled receptors. J. Biol. Chem. 1992, 267, 24045-24052.
99. s. Mol. Pharmacol. 1992, 41, 889-893.
100. Coupry, J.; Duzic, E.; Lanier, S. M. Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors. J. Biol. Chem. 1992, 267, 9852-9857.
101. 1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis. J. Biol. Chem. 1992, 267, 1633-1639.
102. s. J. Biol. Chem. 1991, 266, 4816-4821.
103. s. Mol. Pharmacol. 1992, 41, 1061-1065.
104. Luttrell, L. M.; Ostrowski, J.; Cotecchia, S.; Kendall, H.; Lefkowitz, R. J. Antagonism of catecholamine receptor signaling by expression of cytoplasmic domains of the receptors. Science 1993, 259, 1453-1457.
105. 1B-adrenergic receptors by all amino acid substitutions at a single site. J. Biol. Chem. 1992, 267, 1430-1433.
106. 2-adrenergic receptor that is autoregulated via protein kinase α-dependent phosphorylation. Cell 1991, 67, 723-730.
107. Munch, G.; Dees, C.; Hekman, M.; Palm, D. Multisite contacts involved in coupling of the β-adrenergic receptor with the stimulatory guanine-nucleotide-binding regulatory protein. Structural and functional studies by β-receptor-site-specific synthetic peptides. Eur. J. Biochem. 1991, 198, 357-364.
108. 2-adrenergic receptor. J. Biol. Chem. 1993, 268, 4625-4636.
109. 2-adrenergic receptor. J. Biol. Chem. 1993, 268, 16483-16487.
110. 2-adrenergic receptor to the stimulatory guanine nucleotide binding protein without interfering with receptor down regulation. Biochemistry 1993, 32, 4979-4985.
111. 2-adrenergic receptoragonist interactions. J. Cyclic Nucleotide Protein Phosphorylation Res. 1983, 9, 191-201.
112. s-deficient membranes. Naunyn-Schmiedebergs Arch. Pharmacol. 1986, 333, 124-129.
113. Benovic, J. L.; Mayor, F.; Staniszewski, C.; Lefkowitz, R. J.; Caron, M. G. Purification and characterization of the β-adrenergic receptor kinase. J. Biol. Chem. 1987, 262, 9026-9032.
114. 2- adrenergic receptors. J. Biol. Chem. 1993, 268, 3201-3208.
115. 2-adrenergic receptor. Proc. Natl. Acad. Sci. U. SA. 1993, 90, 3665-3669.
116. 2-adrenergic receptors. J. Biol. Chem. 1992, 267, 25473-25479.
117. s coupling undergoes agonist-promoted desensitization in a subtype-selective manner. Biophys. Res. Commun. 1993, 193, 318-323.
118. 2-adrenergic receptor in Sf9 cells. J. Biol. Chem. 1992, 267, 21733-21737.
119. 2-adrenergic receptor lacking the palmitoylated Cys341. EMBO J. 1993, 12, 349-356.
120. 3H-prazosin binding. Mol. Pharmacol. 1986, 29, 321-330.
121. Jagadeesh, G.; Deth, R. C. Different affinity states of alpha-1 adrenergic receptors defined by agonists and antagonists in bovine aorta plasma membranes. J. Pharmacol. Exp. Ther. 1987, 243, 430-436.
122. 1 receptors associated with vascular smooth muscle: Evidence from functional and ligand binding studies. Life Sci. 1987, 41, 663-673.
123. 3H] prazosin binding sites in canine brain membranes. Brain Res. 1989, 486, 56-66.
124. Piascik, M. T.; Kusiak, J. W.; Pitha, J.; Butler, B. T.; Le, H. T.; Babich, M. Alkylation of alpha-1 receptors with a chemically reactive analog of prazosin reveals low affinity sites for norepinephrine in rabbit aorta. J. Pharmacol. Exp. Ther. 1988, 246, 1001-1011.
125. 1-Adrenoceptor subtypes in bovine prostate. J. Pharm. Pharmacol. 1992, 44, 727-730.
126. 1-Adrenoceptor subtypes in rabbit thoracic aorta. Jpn. J. Pharmacol. 1992, 58 (Suppl. II), 276.
127. 1-adrenoceptor subtypes in dog prostate. Jpn. J. Pharmacol. 1992, 58 (Suppl. II), 174.
128. 1-adrenoceptor subtypes in rabbit thoracic aorta. Br. J. Pharmacol. 1993, 108, 1071-1076.
129. Piascik, M. T.; Butler, B. T.; Pruitt, T. A.; Kusiak, J. W. Agonist interaction with alkylation-sensitive and resistant alpha-1 an- drenoceptor subtypes. J. Pharmacol. Exp. Ther. 1990, 254, 982-991.
130. 1-adrenoceptor subtypes in rat tissues. Pharmacol. Commun. 1993, 3, 323-332.
131. 1-adrenoceptors between rat brain and spleen. Jpn. J. Pharmacol. 1991, 56, 523-530.
132. 3H-prazosin binding and phenoxybenzamine. J. Urol. 1993, 149, 241A.
133. 1-adrenoceptors of canine prostate. FASEB J. 1992, 6, A1021.
134. Hieble, J. P.; Boyce, A. J.; Caine, M. Comparison of the α-adrenoceptor characteristics in human and canine prostate. Fed. Proc. 1986, 45, 2609-2614.
135. 1A-subtype in rat submaxillary gland. Br. J. Pharmacol. 1989, 98, 883-889.
136. 1-adrenergic receptor subtypes; MDCK-D1 cells, but not rat cortical membranes possess a single population of receptors. Mol. Pharmacol. 1991, 39, 407-413.
137. 1- adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101. Mol. Pharmacol. 1988, 33, 509-514.
138. 1-Adrenergic receptor subtypes, inositol phosphates and sources of cell calcium. Pharmacol. Rev. 1988, 40, 87-119.
139. 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. Br. J. Pharmacol. 1989, 97, 691-700.
140. 3H] prazosin binding sites. J. Pharm. Pharmacol. 1989, 41, 714-716.
141. 1-adrenergic receptor binding sites in rat tissues. Mol. Pharmacol. 1991, 40, 531-538.
142. 1-adrenoceptors via radioligand binding. Pharmacologist 1993, 35, 167.
143. 1-adrenoceptors. Soc. Neurosci. Abstr. 1994, 20, 526.
144. 1-adrenergic receptors linked to phosphatidylinositol turnover and cyclic AMP accumulation in rat brain. Mol. Pharmacol. 1987, 31, 239-246.
145. 2-adrenergic receptor binding sites. Eur. J. Pharmacol. 1983, 94, 171-174.
146. 2+ in smooth muscle. Nature 1987, 329, 333-335.
147. 1-adrenoceptor. Eur. J. Pharmacol. 1989, 151, 333-335.
148. Kusiak, J. W.; Pitha, J.; Piascik, M. T. Interaction of a chemically reactive prazosin analog with alpha-1 adrenoceptors of rat tissues. J. Pharmacol. Exp. Ther. 1989, 249, 70-77.
149. 1B-adrenoceptors. Eur. J. Pharmacol. 1991, 208, 113-117.
150. 3H] YM617, a potent and selective alpha-1 adrenoceptor radioligand. J. Pharmacol. Exp. Ther. 1992, 263, 201-206.
151. 1-adrenoceptor antagonist) binding site in rabbit prostate and aorta. Jpn. J. Pharmacol. 1992, 58 (Suppl. II), 173.
152. 2-adrenergic receptors. FASEB J. 1992, 6, 832-839.
153. Kawahara, R. S.; Bylund, D. B. Solubilization and characterization of putative alpha-2 adrenergic isoceptors from the human platelet and the rat cerebral cortex. J. Pharmacol. Exp. Ther. 1985, 233, 603-610.
154. 3H] yohimbine binding in human brain. Life Sci. 1986, 38, 2129-2137.
155. 2B-adrenoceptor antagonist. Br. J. Pharmacol. 1990, 99, 560-564.
156. 2B- adrenoceptor subtypes. Eur. J. Pharmacol. 1989, 168, 381-386.
157. 2C-adrenoceptor. Br. J. Pharmacol. 1992, 107, 222-225.
158. Murphy, T. J.; Bylund, D. B. Characterization of alpha-2 adrenergic receptors in the OK cell, an opossum kidney cell line. J. Pharmacol. Exp. Ther. 1988, 244, 571-578.
159. Blaxall, H. S.; Murphy, T. J.; Baker, J. C.; Ray, C.; Bylund, D. B. Characterization of the alpha-2C adrenergic receptor subtype in the opossum kidney and in the OK cell line. J. Pharmacol. Exp. Ther. 1991, 259, 323-329.
160. 2D-adrenergic receptors in bovine pineal gland. Mol. Pharmacol. 1991, 40, 235-241.
161. 2-adrenoceptors: Implications for receptor classification. Br. J. Pharmacol. 1992, 106, 1011-1018.
162. 2-adrenoceptors in the kidney. Br. J. Pharmacol. 1991, 104, 657-664.
163. 2B-adrenoceptors in rat. Pharmacol. Toxicol. 1993, 72, 40-49.
164. 2? Pharmacol. Commuti. 1995, 6, 109-117.
165. Minneman, K. P.; Hedberg, A.; Molinoff, P. B. Comparison of beta-adrenergic receptor subtypes in mammalian tissues. J. Pharmacol. Exp. Ther. 1979, 211, 502-508.
166. 2-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes. Br. J. Pharmacol. 1993, 109, 1157-1163.
167. Medgett, I. C.; Langer, S. Z. Heterogeneity of smooth muscle alpha-adrenoceptors in the rat tail artery in vitro. J. Pharmacol. Exp. Ther. 1984, 229, 823-830.
168. Agrawal, D. K.; Triggle, C. R.; Daniel, E. E. Pharmacological characterization of the postsynaptic alpha adrenoceptors in vascular smooth muscle from canine and rat mesenteric vascular beds. J. Pharmacol. Exp. Ther. 1984, 229, 831-838.
169. Drew, G. M. What do antagonists tell us about α-adrenoceptors? Clin. Sci. 1985, 68 (Suppl. 10), 15s-19s.
170. Wilson, V. G.; Brown, C. M.; McGrath, J. C. Are there more than two types of α-adrenoceptors involved in physiological responses. Exp. Physiol. 1991, 76, 317-346.
171. 1-adrenoceptor subtypes in dog mesenteric and carotid arteries. Br. J. Pharmacol. 1991, 102, 210-214.
172. 1-adrenoceptors in vascular smooth muscle. Br. J. Pharmacol. 1990, 99, 197-201.
173. 1-adrenoceptor subtypes involved in noradrenaline contraction of rabbit thoracic aorta. Br. J. Pharmacol. 1990, 101, 662-666.
174. 1-adrenoceptors involved in noradrenaline-induced contractions of rat thoracic aorta and dog carotid artery. Jpn. J. Pharmacol. 1991, 57, 535-544.
175. Muramatsu, I.; Yamanaka, K.; Kigoshi, S. Pharmacological profile of the novel α-adrenoceptor antagonist KT-611 (naftopidil). Jpn. J. Pharmacol. 1991, 55, 391-398.
176. Flavahan, N. A.; Vanhoutte, P. M. α-Adrenoceptor subclassification in vascular smooth muscle. Trends Pharmacol. Sci. 1986, 7, 347-349.
177. Hieble, J. P.; Woodward, D. F. Different characteristics of postjunctional alpha-adrenoceptors in arterial and venous smooth muscle. Naunyn-Schmiedeberg’s Arch. Pharmacol. 1984, 328, 44-50.
178. 1-adrenoceptor subtypes mediating the contractile response to norepinephrine in rat vas deferens and spleen. Pharmacologist 1993, 35, 166.
179. 1-adrenoceptors in rat blood vessels. Eur. J. Pharmacol. 1990, 190, 97-104.
180. 1-adrenoceptors in mammalian aortae: subclassification based on chlorethylclonidine, WB 4101 and nifedipine. J. Vase. Res. 1992, 29, 33-40.
181. Coates, J.; Weetman, D. F. Occurrence of alpha-1 adrenoceptor in the mouse but not in the rabbit isolated anococcygeus muscle preparations. Br. J. Pharmacol. 1983, 78, 117-122.
182. Kenakin, T. P. The classification of drugs and drug receptors in isolated tissues. Pharmacol. Rev. 1984, 36, 165-222.
183. James, M. K.; Leighton, H. J. Analysis of putative alpha-1s adrenoceptor antagonism by Sgd 101/75 in the rat anococcygeus muscle. J. Pharmacol. Exp. Ther. 1987, 242, 772-776.
184. 1-Adrenoceptor subtypes in rat thoracic aort defined using abanoquil and other selective antagonists. Br. J. Pharmacol. 1992, 107, 375.
185. Sulpizio, A. C.; Hieble, J. P. Lack of a pharmacological distinction between alpha-1 adrenoceptors mediating intracellular calcium-dependent and independent contractions to sympathetic nerve stimulation in the perfused rat caudal artery. J. Pharmacol. Exp. Ther. 1991, 257, 1045-1052.
186. 1D-subtype. Can. J. Physiol. Pharmacol. 1994, 72 (Suppl. 1), 323.
187. 1β-adrenoceptor in rat spleen. Br. J. Pharmacol. 1992, 107, 324.
188. Laher, I.; Khayal, M. A.; Bevan, J. A. Norepinephrine-sensitive, phenoxybenzamine-resistant receptor sites associated with contraction in rabbit arterial but not venous smooth muscle: Possible role in adrenergic neurotransmission. J. Pharmacol. Exp. Ther. 1986, 237, 364-368.
189. Bylund, D. B.; Ray-Prenger, C. Alpha-2A and alpha-2B adrenergic receptor subtypes: Attenuation of cyclic AMP production in cell lines containing only one receptor subtype. J. Pharmacol. Exp. Ther. 1989, 251, 640-644.
190. 2-adrenoceptors in rat submaxillary gland and heart atrium. Br. J. Pharmacol. 1992, 107, 246-255.
191. 1-adrenoceptors in rat atrium, vas deferens and submandibular gland. Eur. J. Pharmacol. 1992, 211, 251-256.
192. 2-adrenoceptors. Br. J. Pharmacol. 1990, 101, 285-290.
193. 2-autoreceptors on the sympathetic nerves of the rabbit pulmonary artery. Naunyn-Schmiedeberg’s Arch. Pharmacol. 1992, 346, R64.
194. 2c-subtype. Naunyn-Schmideberg’s Arch. Pharmacol. 1993, 347 (Suppl.), 482.
195. 2-adrenoceptor subtypes modulate acetylcholine and noradrenaline release from isolated guinea pig ileum. Pharmacol. Res. 1992, 25 (Suppl. 2), 273-274.
196. 2-adrenoceptors. J. Physiol. 1992, 446, 435.
197. Docherty, J. R. The use of the human saphenous vein in pharmacology. Trends Pharmacol. Sci. 1987, 8, 358-361.
198. 2-adrenoceptors by SK&F 104078. Naunyn-Schmiedeberg’s Arch. Pharmacol. 1987, 336, 415-418.
199. 2-adrenoceptor based on a new selective antagonist, SK&F 104856. J. Pharmacol. Exp. Ther. 1991, 259, 643-652.
200. Oriowo, M. A.; Hieble, J. P.; Ruffolo, R. R., Jr. Evidence for heterogeneity of prejunctional alpha-2 adrenoceptors. Pharmacology 1991, 43, 1-13.
201. 2-Adrenoceptor blocking profile of SK&F 104078: Further evidence for receptor subtypes. Br. J. Pharmacol. 1991, 102, 943-949.
202. 2-adrenoceptors. Pharmacol. Commun. 1995, 6, 91-97.
203. 2-adrenoceptors to characterize subtype selectivity of antagonist binding. Eur. J. Pharmacol. 1993, 246, 219-226.
204. Kaiser, C.; Schwartz, M. S.; Colella, D. F.; Wardell, J. R. Adrenergic agents. 3. Synthesis and adrenergic activity of some catecholamine analogs bearing a substituted sulfonyl or sulfonylalkyl group in the meta position. J. Med. Chem. 1975, 18, 674-683.
205. Ruffolo, R. R., Jr. Important concepts of receptor theory. J. Auton. Pharmacol. 1982, 2, 277-295.
206. Waldeck, B.; Jeppsson, A. B.; Widmark, E. Partial agonism and functional selectivity: A study on β-adrenoceptor mediated effects in tracheal, cardiac and skeletal muscle. Acta Pharmacol. Toxicol. 1986, 58, 209-218.
207. Pittman, R. N.; Reynolds, E. E.; Molinoff, P. B. Relationship between intrinsic activities of agonists in normal and desensitized tissue and agonist-induced loss of beta adrenergic receptors. J. Pharmacol. Exp. Ther. 1984, 230, 614-618.
208. Pittman, R. N.; Molinoff, P. B. Interactions of full and partial agonists with beta-adrenergic receptors on intact L6 muscle cells. Mol. Pharmacol. 1983, 24, 398-408.
209. Hedberg, A.; Mattison, H. Beta-adrenoceptor interaction of full and partial agonists in the cat heart and soleus muscle. J. Pharmacol. Exp. Ther. 1981, 219, 798-808.
210. 1-adrenoceptor selective agonist. Br. J. Pharmacol. 1980, 68, 677-685.
211. Buxton, B. F.; Jones, C. R.; Moleanaar, P.; Summers, R. J. Characterization and autoradiographic localization of β-adrenoceptor subtypes in human cardiac tissues. Br. J. Pharmacol. 1987, 92, 299-310.
212. Naito, K.; Nagao, T.; Otsuka, M.; Harigays, S.; Nakajima, H. Studies on the affinity and selectivity of denopamine (TA-064), a new cardiotonic agent, for β-adrenergic receptor. Jpn. J. Pharmacol. 1985, 38, 235-241.
213. 1-adrenoceptor partial agonist. Br. J. Pharmacol. 1982, 77, 381-388.
214. Kenakin, T. P.; Beek, D. In vitro studies on the cardiac activity of prenalterol with reference to its use in congestive heart failure. J. Pharmacol. Exp. Ther. 1982, 220, 77-85.
215. Levy, B. The adrenergic blocking activity of N-tertiary butylmethoxamine (butoxamine). J. Pharmacol. Exp. Ther. 1966, 151, 413-422.
216. Dunlop, D.; Shanks, R. G. Selective blockade of adrenotropic beta receptors in the heart. Br. J. Pharmacol. Chemother. 1968, 32, 201-218.
217. Levy, B.; Wilkenfeld, B. E. Selective interactions with beta-adrenergic receptors. Fed. Proc. 1970, 29, 1362-1364.
218. 2-adrenoceptors. Eur. J. Pharmacol. 1986, 130, 137-139.
219. 1-Selectivity of bisoprolol, a new β-adrenoceptor antagonist, in anesthetized dogs and guinea pigs. J. Cardiovasc. Pharmacol. 1984, 6, 1156-1160.
220. 3H-(-)-bisoprolol with its blocking potency. Naunyn-Schmiedeberg’s Arch. Pharmacol. 1985, 331, 27-39.
221. 2-selective adrenoceptor antagonist (ICI 118. 551). J. Cardiovasc. Pharmacol. 1983, 5, 430-437.
222. 3H-ICI 118, 551 and blocking potency of ICI 118, 551. Naunyn-Schmiedeberg’s Arch. Pharmacol. 1985, 331, 40-51.
223. 2-adrenoceptors activated by (-)-adrenaline in rat sinoatrial node. Naunyn-Schmiedeberg’s Arch. Pharmacol. 1986, 332, 406-409.
224. Juberg, E. N.; Kenneth, P.; Abel, P. W. b1- and b2-adrenoceptor binding and functional response in right and left atria of rat heart. Naunyn-Schmiedeberg’s Arch. Pharmacol. 1985, 330, 193-202.
225. Akahane, K.; Furukawa, Y.; Ogiwara, Y.; Haniuda, M.; Chiba, S.; Beta 2-adrenoceptor-mediated effects on sinus rate and atrial and ventricular contactility on isolated, blood-perfused dog heart preparations. J. Pharmacol. Exp. Ther. 1989, 248, 1276-1282.
226. 2- adrenoceptor subpopulation. J. Cardiovasc. Pharmacol. 1989, 14, 549-559.
227. McDevitt, D. G. In vivo studies on the function of cardiac β-adrenoceptors in man. Eur. Heart J. 1989, 10 (Suppl. B), 22-28.
228. Ikezono, K.; Zerkowski, H.; Beckringh, J. J.; Michel, M. C.; Brodde, O. Beta-2 adrenoceptor-mediated relaxation of the isolated human saphenous vein. J. Pharmacol. Exp. Ther. 1987, 241, 294-299.
229. 2-adrenoceptors. Br. J. Pharmacol. 1985, 84, 463-468.
230. Purdy, R. E.; Stupecky, G. L.; Coulombe, R. Further evidence for a homogeneous population of beta-1 adrenoceptors in bovine coronary artery. J. Pharmacol. Exp. Ther. 1988, 245, 67-71.
231. Nakane, T.; Tsujimoto, G.; Hashimoto, K.; Chiba, S. Beta adrenoceptors in the canine large coronary arteries: beta-1 adrenoceptors predominate in vasodilation. J. Pharmacol. Exp. Ther. 1988, 245, 936-943.
232. Tenner, T. E., Jr.; Young, J. A.; Earley, K. J.; Yen, J. C. Functional characterization of β-adrenoceptor subtypes in rabbit rat atria. Life Sci. 1989, 44, 651-660.
233. Hollenga, C.; Zaagsma, J. Direct evidence for the atypical nature of functional β-adrenoceptors in rat adipocytes. Br. J. Pharmacol. 1989, 98, 1420-1424.
234. Harms, H. H.; Zaagsma, J.; de Vente, J. Differentiation of β-adrenoceptors in right atrium, diaphragm, and adipose tissue of the rat, using stereoisomers of propranolol, alprenolol, nifenalol and practolol. Life Sci. 1977, 21, 123-138.
235. Harms, H. H. Stereochemical aspects of β-adrenoceptor antagonist-receptor interaction in adipocytes: differentiation of β-adrenoceptors in human and rat adipocytes. Life Sci. 1976, 19, 1447-1452.
236. 2-adrenoceptor”? Trends Pharmacol. Sci. 1990, 11, 3-7.
237. 3H]- dihydroalprenolol binding to rat adipocyte membranes: an explanation of curvilinear Scatchard plots and implications for quantitation of β-adrenergic sites. J. Lipid Res. 1982, 23, 1001-1008.
238. Bahouth, S. W.; Malbon, C. C. Subclassification of β-adrenergic receptors of rat fat cells: a re-evaluation. J. Pharmacol. Exp. Ther. 1988, 247, 318-326.
239. Challis, R. A. J.; Leighton, B.; Wilson, S.; Thurlby, P. L.; Arch, J. R. S. An investigation of the β-adrenoceptor that mediates metabolic responses to the novel agonist BRL 28410 in rat soleus muscle. Biochem. Pharmacol. 1988, 37, 947-950.
240. Bojanic, D.; Nahorski, S. R. Irreversible antagonism of beta- adrenoceptors with para-amino-benzyl-carazolol provides further evidence for an atypical rat adipocyte beta-adrenoceptor. J. Recept. Res. 1984, 4, 21-35.
241. Nicholls, D. G.; Locke, R. M. Thermogenic mechanisms in brown fat. Physiol. Rev. 1984, 64, 1-64.
242. Rothwell, N. J.; Stock, M. J. A role for brown adipose tissue in diet-induced thermogenesis. Nature 1979, 281, 31-35.
243. Suderà, D. K.; Stock, M. J. Confirmation of an “atypical” β-adrenoceptor on rat brown adipose tissue. In Proc. 1st Eur. Congr. Obesity, Stockholm, Sweden, 1988; Abstr. No. 54.
244. Walter, M.; Lemoine, H.; Kaumann, A. J. Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of guinea pig: role of β-adrenoceptor subtypes in the dissociation between blockade and stimulation. Naunyn- Schmiedeberg’s Arch. Pharmacol. 1984, 327, 159-175.
245. Kaumann, A. J. Is there a third heart β-adrenoceptor? Trends Pharmacol. Sci. 1989, 10, 34-38.
246. Bond, R. A.; Clarke, D. E. Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the alpha- and beta-subtypes. Br. J. Pharmacol. 1988, 95, 723-734.
247. Blue, D. R.; Bond, R. A.; Clarke, D. E. Blockade of putative adrenoceptor in guinea pig ileum by alprenolol. Br. J. Pharmacol. 1988, 95, 541P.
248. Blue, D. R.; Bond, R. A.; Adham, N.; Delmondo, R.; Michel, A. D.; Eglen, R. M.; Whiting, R. L.; Clarke, D. E. Interaction of dihydroalprenolol and cyanopindolol with atypical β-adrenoceptors in guinea-pig ileum. Br. J. Pharmacol. 1989, 96, 246P.
249. Croci, T.; Cecchi, R.; Tarantino, A.; Aureggi, G.; Bianchetti, A.; Goigegrain, R.; Manara, L. Inhibition of rat colon motility by stimulation of atypical β-adrenoceptors with new gut-specific agents. Pharmacol. Res. Commun. 1988, 20, 147-151.
250. Guidice, A.; Croci, T.; Bianchetti, A.; Manara, L. Inhibition of rat colonic motility and cardiovascular effects of new gut-specific β-adrenergic phenylethanolaminotetralines. Life Sci. 1989, 44, 1411-1417.
251. McLaughlin, D. P.; McDonald, A. Responses to catecholamines in rat distal colon may be mediated, in part, by “atypical” β-adrenoceptors. Br. J. Pharmacol. 1989, 98, 657.
252. van der Graaf, P. H.; Welsh, N. J.; Shankley, N. P.; Black, J. W. “Functional inhibition curves” provide further evidence for heterogeneity of αi-adrenoceptors in the rat aorta. Br. J. Pharmacol. 1994, 112, 216P.
253. 1-adrenoceptors in the rat aorta. Br. J. Pharmacol. 1993, 110, 124P.
254. 1-adrenoceptor antagonist. Pharmacol. Commun. 1995, 6, 79-86.
255. 1C- adrenoceptor: Functional characterization in prostate. Br. J. Pharmacol. 1992, 107, 327P.
256. 1C- Biochem. Biophys. Res. Commun. 1994, 20, 1296-1304.
257. Hieble, J. P.; Naselsky, D. P. Determination of α2-adrenoceptor subtype selectivity in tissue homogenates and cell lines. Pharmacologist 1993, 35, 166.
258. 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH DPAT, RU 24969 and methylsergide. Br. J. Pharmacol. 1990, 99, 481-486.
259. 3H-yohimbine, a selective antagonist ligand. Life Sci. 1982, 28, 2705-2717.
260. Gleason, M. M.; Hieble, J. P. Ability of SK&F 104078 and SK&F 104856 to identify alpha-2 adrenoceptor subtypes in NCB20 cells and guinea pig lung. J. Pharmacol. Exp. Ther. 1991, 259, 1124-1132.
261. 2A-adrenoceptors. Eur. J. Pharmacol. 1989, 167, 95-104.
262. 2-adrenergic binding sites. Mol. Pharmacol. 1990, 37, 876-885.
263. 2-adrenoceptors: Variations in alpha-2 and beta adrenergic receptor distribution according to the extent of the fat deposits and the anatomical location. J. Pharmacol. Exp. Ther. 1987, 242, 1041-1049.
264. 2B-adrenoceptor subtypes. Br. J. Pharmacol. 1989, 98, 890-897.
265. Bylund, D. B.; Ray-Prenger, C.; Murphy, T. J. Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one receptor subtype. J. Pharmacol. Exp. Ther. 1988, 245, 600-607.
266. 2B-adrenergic receptor. Mol. Pharmacol. 1990, 38, 681-688.
267. 2B- adrenergic receptor. Proc. Natl. Acad. Sci. U. S. A, 1991, 88, 1019-1023.
268. 2-adrenoceptors. Eur. J. Pharmacol. 1989, 171, 145-157.
269. 3H]idazoxan-labelled non-adrenergic sites in rabbit white fat cells. Eur. J. Pharmacol., Mol. Pharmacol. Sect. 1990, 188, 261-272.
270. Carpene, C.; Galitzky, J.; Larrouy, D.; Langin, D.; Lafontan, M. Non-adrenergic sites for imidazoles are not directly involved in the α2-adrenergic antilipolytic effect of UK 14, 304 in rat adipocytes. Biochem. Pharmacol. 1990, 40, 437-445.
271. 3H] RX 821002 and distribution along the villus-crypt axis. J. Pharmacol. Exp. Ther. 1990, 254, 888-893.
272. 2D adrenoceptor and nonadrenergic idazoxan binding sites. J. Pharmacol. Exp. Ther. 1992, 260, 417-426.
273. 1-adrenoceptors of rabbit and rat liver membranes. Life Sci. 1993, 53, 177-181.